Showing 1 - 4 results of 4 for search 'Willekens, C', query time: 0.02s
Refine Results
-
1
Clonal heterogeneity in differentiation response and resistance to the IDH2 inhibitor enasidenib in acute myeloid leukemia by Quek, L, David, M, Kennedy, A, Metzner, M, Amatangelo, M, Shih, A, Stoilova, B, Karamitros, D, Quivoron, C, Heiblig, M, Willekens, C, Saada, V, Peniket, A, Bernard, O, Agresta, S, Yen, K, Stein, E, De Botton, S, Thakurta, A, Levine, R, Penard-Lacronique, V, Vyas, P
Published 2017Conference item -
2
Clonal heterogeneity of acute Myeloid Leukemia treated with the IDH2 inhibitor Enasidenib by Vyas, P, Quek, L, David, MD, Kennedy, A, Metzner, M, Amatangelo, M, Shih, A, Stoilova, B, Quivoron, C, Heiblig, M, Willekens, C, Saada, V, Alsafadi, S, Vijayabaskar, MS, Peniket, A, Bernard, OA, Agresta, S, Yen, K, MacBeth, K, Stein, E, Vassiliou, GS, Levine, R, De Botton, S, Thakurta, A, Penard-Lacronique, V
Published 2018Journal article -
3
SRSF2-P95H decreases JAK/STAT signaling in hematopoietic cells and delays myelofibrosis development in mice by Willekens, C, Laplane, L, Dagher, T, Benlabiod, C, Papadopoulos, N, Lacout, C, Rameau, P, Catelain, C, Alfaro, A, Edmond, V, Signolle, N, Marchand, V, Droin, N, Hoogenboezem, R, Schneider, RK, Penson, A, Abdel-Wahab, O, Giraudier, S, Pasquier, F, Marty, C, Plo, I, Villeval, J-L, Constantinescu, SN, Porteu, F, Vainchenker, W, Solary, E
Published 2023Journal article -
4
Enasidenib in mutant IDH2 relapsed or refractory acute myeloid leukemia by Stein, EM, DiNardo, CD, Pollyea, DA, Fathi, AT, Roboz, GJ, Altman, JK, Stone, RM, DeAngelo, DJ, Levine, RL, Flinn, IW, Kantarjian, HM, Collins, R, Patel, MR, Frankel, AE, Stein, A, Sekeres, MA, Swords, RT, Medeiros, BC, Willekens, C, Vyas, P, Tosolini, A, Xu, Q, Knight, RD, Yen, KE, Agresta, S, De Botton, S, Tallman, MS
Published 2017Journal article